Brain Sciences Center, US Department of Veterans Affairs Medical Center (11B), Minneapolis, MN 55417, USA.
J Neural Eng. 2010 Feb;7(1):16011. doi: 10.1088/1741-2560/7/1/016011. Epub 2010 Jan 20.
Traumatic experiences can produce post-traumatic stress disorder (PTSD) which is a debilitating condition and for which no biomarker currently exists (Institute of Medicine (US) 2006 Posttraumatic Stress Disorder: Diagnosis and Assessment (Washington, DC: National Academies)). Here we show that the synchronous neural interactions (SNI) test which assesses the functional interactions among neural populations derived from magnetoencephalographic (MEG) recordings (Georgopoulos A P et al 2007 J. Neural Eng. 4 349-55) can successfully differentiate PTSD patients from healthy control subjects. Externally cross-validated, bootstrap-based analyses yielded >90% overall accuracy of classification. In addition, all but one of 18 patients who were not receiving medications for their disease were correctly classified. Altogether, these findings document robust differences in brain function between the PTSD and control groups that can be used for differential diagnosis and which possess the potential for assessing and monitoring disease progression and effects of therapy.
创伤性经历可导致创伤后应激障碍(PTSD),这是一种使人衰弱的疾病,目前尚无生物标志物(美国医学研究所(US)2006 年《创伤后应激障碍:诊断和评估》(华盛顿特区:国家科学院))。在这里,我们展示了同步神经相互作用(SNI)测试,该测试评估了从脑磁图(MEG)记录中获得的神经群体之间的功能相互作用(Georgopoulos AP 等人,2007 年《神经工程杂志》4 349-55),可成功区分 PTSD 患者和健康对照组。经过外部交叉验证和基于引导的分析,分类的总体准确率超过 90%。此外,在未服用药物治疗疾病的 18 名患者中,除 1 名外,其余患者均被正确分类。总之,这些发现记录了 PTSD 组和对照组之间大脑功能的显著差异,可用于鉴别诊断,并具有评估和监测疾病进展和治疗效果的潜力。